Correction to: An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients

Abstract

This is a corrigendum to Clin Pharmacokinet. 2022 Apr 4 An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients concerning a correction in the simulations of piperacillin and tazobactam concentrations with the developed pharmacokinetic model. In the original simulation dataset, by accident double doses were entered. The exposure of both piperacillin and tazobactam based on the new corrected simulations is 50% of the exposure presented in the original publication. This applies to the following sections of the article: abstract, results, discussion, conclusion, Figs. 3, 4, 5 and Tables 3 and 4. Therefore, all simulated piperacillin and tazobactam concentrations in the original manuscript should be divided by 2. The published model does not contain any errors, as the error concerns only the performed simulations. Although